News
HUB and Dutch Health Insurance Companies to Validate Use of Organoids for Cystic Fibrosis
Hubrecht Organoid Technology (HUB), and the health insurance companies CZ, Zilveren Kruis, and Menzis announced that they will start a €3 million validation trial for use of HUB Organoid Technology to test if it can be used to determine the response of Cystic Fibrosis (CF) patients to new drug therapies.Incyte and Merus Announce Global Strategic Research Collaboration to Discover and Develop Bispecific Antibodies
Incyte Corporation and Merus N.V. announced that they have entered into a global, strategic collaboration agreement focused on the research, discovery and development of bispecific antibodies utilizing Merus’ proprietary Biclonics® technology platform.TNO publish report on Public-Private Partnerships
Vandaag heeft minister Kamp van Economische Zaken uit handen van Paul de Krom, CEO van TNO de publicatie De Staat van Nederland Innovatieland 2016 (SNI2016) ontvangen.
Dutch start-up Core Life Analytics to rescue scientists who are drowning in data.
Utrecht technology start-up, Core Life Analytics BV, has on December 19th 2016, signed an agreement with the UMC Utrecht for exclusive rights to commercialize HC StratoMineR, a data analytics platform developed at the UMCU.Are you active in the United States and want to help?
In 2017, special attention will be paid to the health sector in the United States and its opportunities for the Dutch Life Sciences & Health (LSH) sector. Are you active in the US and want to help by answering a short survey?Health~Holland Update November 2016
In this edition, we provide an update on the Venture Challenge winner, new National Icons, deadlines for the Match Call in 2017, and the second Create Health call. We are proud to present the new Life Sciences education roadmap and we highlight two public-private partnerships. Finally, we shed light on some national and international events and missions.
3D-PharmXchange and Mirabilis organize Round Table Meeting to discuss microRNA/Genetherapy issues
Exciting developments in the biotech sector are occurring in the relatively new fields of Gene Therapy and MicroRNA’s. Although the Netherlands and Belgium are frontrunners in the field, there are still some hurdles to overcome. With this in mind, 3D-PharmXchange and Mirabilis, with support of Health~Holland and HollandBIO, organized a round table meeting.RadiQual Surgery: winner of the Venture Challenge Fall 2016
RadiQual Surgery has developed a worldwide unique product called Logi-Knife that enables surgeons to make use of high quality diagnostic imaging data for real-time 3D surgical navigation during their surgical procedures. Using Logi-Knife, surgeons are able to perform the perfect cut to cure cancer.